| Taking temperature—A review of European Union regulation in nanomedicine G Van Calster, J D'Silva European Journal of Health Law 16 (3), 249-269, 2009 | 45 | 2009 |
| To Label or Not to Label?–It's More than a Nano-sized Question J D’Silva, DM Bowman European Journal of Risk Regulation 1 (4), 420-427, 2010 | 20 | 2010 |
| A game with rules in the making–how the high probability of waiting games in nanomedicine is being mitigated through distributed regulation and responsible innovation J d'Silva, DKR Robinson, C Shelley-Egan Technology Analysis & Strategic Management 24 (6), 583-602, 2012 | 19 | 2012 |
| Pools, thickets and open source nanotechnology J D'Silva European intellectual property review 31 (6), 300-306, 2009 | 18 | 2009 |
| Knowledge transfer from citizens’ panels to regulatory bodies in the domain of nano-enabled medical applications J Evers, J D'Silva Innovation–the European journal of social science research 22 (1), 125-142, 2009 | 18 | 2009 |
| Defining nanomaterials for the purpose of regulation within the European Union D Bowman, J D'Silva, G Van Calster European Journal of Risk Regulation 1 (2), 115-122, 2010 | 16 | 2010 |
| Regulating nanomedicine: a European perspective J D’Silva, G Van Calster Nature Precedings, 1-1, 2008 | 13 | 2008 |
| The Status of Consumers in European Water Regulation, Environmental Law and Consumer Protection H Van Rijswick Revue europeénne de droit de la consommation 2011 (1), 115-148, 2011 | 9 | 2011 |
| Nanotechnology: development, risk and regulation J D’Silva Paper for the British and Irish Law, Education and Technology Association …, 2007 | 8 | 2007 |
| Protecting consumers or failing them? The regulation of nanotechnologies in the EU G van Calster, DM Bowman, J D'Silva European Journal of Consumer Law 1, 85-113, 2011 | 7 | 2011 |
| What's in a name?–Defining a ‘nanomaterial’for regulatory purposes in Europe J D'Silva European Journal of Risk Regulation 2 (1), 85-91, 2011 | 7 | 2011 |
| For me to know and you to find out? Participatory mechanisms, the Aarhus Convention and new technologies J D'Silva, G van Calster Studies in Ethics, Law, and Technology 4 (2), 2010 | 7 | 2010 |
| The regulation of nanomedicine J D’Silva, D Bowman Nanomedicine in health and disease, 20, 2011 | 5 | 2011 |
| Why the elephant in the room appears to be more than a nano-sized challenge J D'Silva, DM Bowman European Journal of Law and Technology 2 (3), 2011 | 2 | 2011 |
| Trust me, I’ma regulator. The (in) adequacy of EU legislative instruments for three nanotechnologies categories G Van Calster, D Bowman, J D’Silva Dimensions of technology regulation. Proceedings of the TILT Conference, 207-37, 2008 | 2 | 2008 |
| Regulatory Aspects of Nanomedicine in Europe J D'Silva Pan Stanford Publishing, Singapore, 2012 | 1 | 2012 |
| The ‘wicked’problem of regulating nanotechnologies: Local and global challenges DM BOWMAN, J D’SILVA ENGAGEMENTS, 139, 2011 | 1 | 2011 |
| Intellectual property and regulatory issues at the nanoscale J D’Silva Size Matters–Ethical, Legal and Social Aspects of Nanobiotechnology and Nano …, 2008 | 1 | 2008 |
| Scientists and the Regulation of Risk: Standardising Control J D'Silva SCIENCE AND PUBLIC POLICY 40 (5), 701-703, 2013 | | 2013 |
| Standards, Risk and the Scientist J D'Silva Science and Public Policy 40 (5), 701-703, 2013 | | 2013 |
